Stuart Isaacson
Baylor College of Medicine(US)Parkinson's Research and Education Foundation(US)Phillips University(US)
Publications by Year
Research Areas
Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Botulinum Toxin and Related Neurological Disorders, Restless Legs Syndrome Research, Attention Deficit Hyperactivity Disorder
Most-Cited Works
- → Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial(2013)930 cited
- → The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension(2017)432 cited
- → Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti–α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease(2018)285 cited
- → Inosine to Increase Serum and Cerebrospinal Fluid Urate in Parkinson Disease(2014)238 cited
- → ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study)(2017)171 cited
- → Randomized, placebo‐controlled trial of ADS‐5102 (amantadine) extended‐release capsules for levodopa‐induced dyskinesia in Parkinson's disease (EASE LID 3)